• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vitiligo-like lesions and immune checkpoint inhibition therapy: is it truly an adverse event exclusive to patients with melanoma?

作者信息

Rodríguez-Lomba E, Molina-López I, Suárez-Fernández R, Baniandrés-Rodríguez O

机构信息

Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

出版信息

Clin Exp Dermatol. 2018 Jul;43(5):598-599. doi: 10.1111/ced.13382. Epub 2018 Jan 14.

DOI:10.1111/ced.13382
PMID:29333653
Abstract
摘要

相似文献

1
Vitiligo-like lesions and immune checkpoint inhibition therapy: is it truly an adverse event exclusive to patients with melanoma?白癜风样皮损与免疫检查点抑制疗法：它真的是黑色素瘤患者独有的不良事件吗？
Clin Exp Dermatol. 2018 Jul;43(5):598-599. doi: 10.1111/ced.13382. Epub 2018 Jan 14.
2
[Managing the Adverse Effects Related to Immune Checkpoint Inhibitors].[管理与免疫检查点抑制剂相关的不良反应]
Hu Li Za Zhi. 2018 Jun;65(3):88-95. doi: 10.6224/JN.201806_65(3).12.
3
Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.用于肝细胞癌和病毒性肝炎的特异性CD8(+) T细胞应答免疫疗法。
World J Gastroenterol. 2016 Jul 28;22(28):6469-83. doi: 10.3748/wjg.v22.i28.6469.
4
Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors.检查点抑制剂所致的结节病样综合征和淋巴结病
J Oncol Pharm Pract. 2017 Dec;23(8):620-624. doi: 10.1177/1078155216667635. Epub 2016 Sep 2.
5
Vitiligo-like depigmentation in oncology patients treated with immunotherapies for nonmelanoma metastatic cancers.肿瘤患者接受非黑色素瘤转移性癌症免疫治疗后出现白癜风样脱色。
Clin Exp Dermatol. 2019 Aug;44(6):643-646. doi: 10.1111/ced.13867. Epub 2019 Jan 7.
6
Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients.类似疾病复发的结节性红斑样脂膜炎：免疫检查点阻断疗法的一种新型毒性——2例报告
J Cutan Pathol. 2017 Dec;44(12):1080-1086. doi: 10.1111/cup.13044. Epub 2017 Oct 13.
7
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.程序性细胞死亡蛋白1或联合程序性死亡蛋白1/细胞毒性T淋巴细胞相关抗原4抑制治疗转移性葡萄膜黑色素瘤的预后因素及结局
Eur J Cancer. 2017 Sep;82:56-65. doi: 10.1016/j.ejca.2017.05.038. Epub 2017 Jun 22.
8
[Immune-related adverse events by immune checkpoint inhibitors].免疫检查点抑制剂相关的免疫不良反应
Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(2):83-89. doi: 10.2177/jsci.40.83.
9
Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors.患者患有葡萄膜黑色素瘤，接受免疫检查点抑制剂治疗后，同一 T 细胞克隆引起的异常反应和多系统自身免疫样毒性。
J Immunother Cancer. 2019 Mar 4;7(1):61. doi: 10.1186/s40425-019-0533-0.
10
Immune checkpoint inhibitor-associated hypophysitis-World Health Organisation VigiBase report analysis.免疫检查点抑制剂相关垂体炎——世界卫生组织药物不良反应数据库报告分析
Eur J Cancer. 2019 May;113:10-13. doi: 10.1016/j.ejca.2019.03.002. Epub 2019 Apr 4.

引用本文的文献

1
The Role of Immunotherapy and Radiation Therapy in the Treatment of Breast Cancer.免疫疗法和放射疗法在乳腺癌治疗中的作用。
Biomedicines. 2025 Sep 9;13(9):2209. doi: 10.3390/biomedicines13092209.
2
Targeted therapies induced depigmentation: a review.靶向治疗引起的色素脱失：综述
Front Immunol. 2025 Aug 8;16:1625738. doi: 10.3389/fimmu.2025.1625738. eCollection 2025.
3
Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence.免疫检查点抑制剂相关的皮肤不良事件：发生机制
Int J Mol Sci. 2024 Dec 26;26(1):88. doi: 10.3390/ijms26010088.
4
Immune checkpoint inhibitor-induced vitiligo in cancer patients: characterization and management.免疫检查点抑制剂诱导的癌症患者白癜风：特征与管理。
Arch Dermatol Res. 2023 Aug;315(6):1697-1703. doi: 10.1007/s00403-023-02577-7. Epub 2023 Feb 21.
5
Targeting the PD-1/PD-L1 Axis in Human Vitiligo.靶向 PD-1/PD-L1 轴治疗人类白癜风。
Front Immunol. 2020 Nov 6;11:579022. doi: 10.3389/fimmu.2020.579022. eCollection 2020.
6
Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.免疫疗法治疗转移性黑色素瘤：现有知识和未来方向。
J Immunol Res. 2020 Jun 28;2020:9235638. doi: 10.1155/2020/9235638. eCollection 2020.
7
Immune checkpoint inhibitor-related dermatologic adverse events.免疫检查点抑制剂相关的皮肤不良反应。
J Am Acad Dermatol. 2020 Nov;83(5):1255-1268. doi: 10.1016/j.jaad.2020.03.132. Epub 2020 May 23.
8
Treatment Outcomes of Immune-Related Cutaneous Adverse Events.免疫相关性皮肤不良反应的治疗结果。
J Clin Oncol. 2019 Oct 20;37(30):2746-2758. doi: 10.1200/JCO.18.02141. Epub 2019 Jun 19.
9
Vitiligo-like lesions in a patient treated with nivolumab for renal cell carcinoma.一名接受纳武单抗治疗肾细胞癌的患者出现白癜风样皮损。
Medicine (Baltimore). 2018 Dec;97(52):e13810. doi: 10.1097/MD.0000000000013810.